Chelsea Therapeutics International Ltd names Joseph Oliveto as vice president, operations

Jun 18, 2008 (M2 EQUITYBITES via COMTEX) -- CHTP | Quote | Chart | News | PowerRating -- Chelsea Therapeutics International Ltd (NasdaqCM:CHTP), a biopharmaceutical development company, declared on 17 June that the company has hired Joseph G Oliveto as vice president of operations.

Oliveto, in his new position, will oversee key areas of the company's day-to-day operations, providing leadership for project management, manufacturing and operational aspects of commercialisation activity for Droxidopa. Most recently, Oliveto was employed with Chelsea Therapeutics for a two-year assignment as executive in residence at Pappas Ventures, a life sciences venture capital firm. In addition, he served in a number of progressively senior positions at Hoffmann-La Roche, most recently as the global alliance director for Roche's licensing organisation.

Oliveto brings to the company nearly 20 years of global pharmaceutical experience in the areas of licensing, project management, clinical development and manufacturing.

Comments on this story may be sent to admin@m2.com

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index